The effect of low volume sprint interval training in patients with non-alcoholic fatty liver disease

Autor: John F. Dillon, John A. Babraj, Niels B. J. Vollaard, Catriona MacLean
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Adult
Male
medicine.medical_specialty
Physical fitness
Blood Pressure
Physical Therapy
Sports Therapy and Rehabilitation

Walking
High-Intensity Interval Training
Interval training
Running
03 medical and health sciences
Cognition
Oxygen Consumption
0302 clinical medicine
Insulin resistance
physical function
Non-alcoholic Fatty Liver Disease
Internal medicine
NAFLD
Activities of Daily Living
medicine
Humans
all-out
Orthopedics and Sports Medicine
Exercise
Platelet Count
business.industry
Fatty liver
NASH
Disease Management
030229 sport sciences
Middle Aged
medicine.disease
SIT
Endocrinology
Blood pressure
Liver
Sprint
Cardiovascular Diseases
Physical Fitness
liver function
Body Composition
Quality of Life
Female
030211 gastroenterology & hepatology
Liver function
Insulin Resistance
business
High-intensity interval training
ISSN: 0091-3847
Popis: Objectives: Exercise is an important part of disease management in patients with non-alcoholic fatty liver disease (NAFLD), but adherence to current exercise recommendations is poor. Novel low-volume sprint interval training (SIT) protocols with total training time commitments of ≤30 min per week have been shown to improve cardiometabolic risk and functional capacity in healthy sedentary participants, but the efficacy of such protocols in the management of NAFLD remains unknown. The aim of the present study was to examine whether a low-volume SIT protocol can be used to improve liver function, insulin resistance, body composition, physical fitness, cognitive function and general well-being in patients with NAFLD. Methods: In the present study, 7 men and 2 women with NAFLD (age: 45±8 y, BMI: 28.7±4.1 kg·m−2) completed a 6-week control period followed by 6 weeks of twice-weekly SIT sessions (5-10×6-s ‘all-out’ cycle sprints). Body composition, blood pressure, liver function, metabolic function, functional capacity, cognitive function and quality of life were assessed at baseline, following the control period, and following the SIT intervention. Results: Walking speed during the walk test (+12%), estimated V̇O2max (+8%), verbal fluency (+44%), and blood platelet count (+12%; all p
Databáze: OpenAIRE